Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

IMP dehydrogenase inhibitor synthesized at Roche Bioscience

May 17, 1996

CD45RB for organ transplant rejection

May 10, 1996

Cel-Sci announces promising results with TB vaccine

May 10, 1996

Axis Genetics scales up CVP production in anticipation of clinical trials

May 10, 1996

New immunosuppressants from Tsumura

May 10, 1996

Positive results obtained in AllerVax Cat trial

May 3, 1996

HemispheRx, Helix will codevelop nucleic acid compounds

May 3, 1996

ALT expected to receive streamlined review at FDA

May 3, 1996

Centeon to codevelop Medarex's MDX-33

May 3, 1996

New immunosuppressants from Shionogi

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 15, 2025.
ASGCT 2025: Gene and cell therapies transform metabolic diseases
BioWorld Science
Metabolic disorders such as argininosuccinic and glutaric aciduria, methylmalonic acidemia, homocystinuria or primary hyperoxaluria require specific diets to...
Abbott studies show CGM users have fewer hospitalizations
BioWorld MedTech
A pair of studies published in Diabetologia demonstrate that use of continuous glucose monitors (CGMs) reduces hospitalizations in people with type 1 diabetes and...
Rznomics in $1.3B Lilly pact to make hearing loss RNA editor drug
BioWorld
Rznomics Inc. scored a potential ₩1.9 trillion (US$1.35 billion) global license option agreement with Eli Lilly and Co. to codevelop a novel RNA editing gene...